RecruitingNCT05721859
M-Vizion™ Macroscopic Radiographic Study
Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study
Sponsor
Medacta USA
Enrollment
70 participants
Start Date
Oct 12, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
Eligibility
Min Age: 21 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called revision hip arthroplasty for people with revision hip arthroplasty. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 21 Years to 80 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICErevision hip arthroplasty
revision hip arthroplasty
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05721859
Related Trials
Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System
NCT076532954 locations
COMPlex REconStructive Surgery Outcomes Registry (CompResSOR): a clinical outcomes registry for patients undergoing complex orthopaedic reconstructive surgery.
ACTRN126210014218201 location